NasdaqGS - Delayed Quote USD

LifeStance Health Group, Inc. (LFST)

5.83
-0.01
(-0.17%)
At close: May 20 at 4:00:01 PM EDT

Research Analysis

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 332.97M
Earnings 20M

Q2'24

Q3'24

Q4'24

Q1'25

0
100M
200M
300M
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

8.00
8.86 Average
5.83 Current
10.00 High

Earnings Estimate

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
No. of Analysts 1111
Avg. Estimate 0.010.020.060.09
Low Estimate 0.010.020.060.09
High Estimate 0.010.020.060.09
Year Ago EPS 0.010.030.060.06

Revenue Estimate

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
No. of Analysts 7788
Avg. Estimate 347.33M359.12M1.41B1.61B
Low Estimate 339.75M355.22M1.4B1.57B
High Estimate 352.5M365.9M1.42B1.64B
Year Ago Sales 312.33M312.72M1.25B1.41B
Sales Growth (year/est) 11.20%14.84%13.04%13.88%

Earnings History

Currency in USD 6/30/2024 9/30/2024 12/31/2024 3/31/2025
EPS Est. -0.01-0.01-00.01
EPS Actual 0.010.030.020.05
Difference 0.020.040.020.04
Surprise % 221.62%291.23%501.64%311.58%

EPS Trend

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
Current Estimate 0.010.020.060.09
7 Days Ago 0.0100.030.06
30 Days Ago 0.0100.030.06
60 Days Ago 0.0100.030.06
90 Days Ago 0.0100.030.06

EPS Revisions

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
Up Last 7 Days --111
Up Last 30 Days --111
Down Last 7 Days 1------
Down Last 30 Days 1------

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
LFST -41.56%-29.53%1.01%47.01%
S&P 500 13.32%2.69%7.77%13.75%

Upgrades & Downgrades

Initiated Keybanc: Overweight 4/8/2025
Initiated Canaccord Genuity: Buy 4/3/2025
Upgrade Goldman Sachs: Neutral to Buy 12/16/2024
Maintains Barclays: Underweight to Underweight 11/11/2024
Maintains UBS: Neutral to Neutral 8/15/2024
Maintains Barclays: Underweight to Underweight 8/9/2024

Related Tickers